European Union · Record · QUESTION_WRITTEN_PRIORITY
P-8-2017-003716
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
Introduced
2 June 2017
Last action
2 June 2017 · Written question
Status
QUESTION_WRITTEN_PRIORITY
Sponsors
Piernicola PEDICINI
Subjects
Discovery layer
Source updated
2 June 2017
Official titles
Authentic titles published by the source. The stored canonical title is not replaced.
1 official language
English
Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa
Records
Official record P-8-2017-003716 from European Union at European Parliament. Dated 2 June 2017. Status: QUESTION_WRITTEN_PRIORITY.
Timeline
2 June 2017
Written question
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
Source: QUESTION_WRITTEN_PRIORITY
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
11 official files
Answer
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Answer
QUESTION_WRITTEN_ANSWER
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Farmacovigilanza e divulgazione al pubblico di informazioni relative alla sicurezza del vaccino esavalente Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · IT · 7 June 2018
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Pharmacovigilance and public disclosure of information concerning the safety of the hexavalent vaccine Infanrix Hexa
QUESTION_WRITTEN_PRIORITY · EN · 7 June 2018
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Piernicola PEDICINI · AUTHOR
- · COM · ADDRESSEE
- · EU_COMMISSION · ADDRESSEE
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/P-8-2017-003716_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/P-8-2017-003716
- eu · P-8-2017-003716 · source updated 2 June 2017